481. A prospective comparison of short term results and functional recovery after laparoscopic subtotal colectomy and antiperistaltic cecorectal anastomosis with short colonic reservoir vs. long colonic reservoir.
作者: Dong Wei.;Jian Cai.;Yang Yang.;Ting Zhao.;Hui Zhang.;Changshan Zhang.;Yuanyao Zhang.;Jianfeng Zhang.;Fengbo Cai.
来源: BMC Gastroenterol. 2015年15卷30页
To observe and compare the short term results and functional recovery of laparoscopic subtotal colectomy with antiperistaltic cecorectal anastomosis (LSCACRA) in the treatment of Adult slow transit constipation (STC) with two different reservoir length: short colonic reservoir and long colonic reservoir.
482. Preoperative endoscopic versus percutaneous transhepatic biliary drainage in potentially resectable perihilar cholangiocarcinoma (DRAINAGE trial): design and rationale of a randomized controlled trial.
作者: Jimme K Wiggers.;Robert J S Coelen.;Erik A J Rauws.;Otto M van Delden.;Casper H J van Eijck.;Jeroen de Jonge.;Robert J Porte.;Carlijn I Buis.;Cornelis H C Dejong.;I Quintus Molenaar.;Marc G H Besselink.;Olivier R C Busch.;Marcel G W Dijkgraaf.;Thomas M van Gulik.
来源: BMC Gastroenterol. 2015年15卷20页
Liver surgery in perihilar cholangiocarcinoma (PHC) is associated with high postoperative morbidity because the tumor typically causes biliary obstruction. Preoperative biliary drainage is used to create a safer environment prior to liver surgery, but biliary drainage may be harmful when severe drainage-related complications deteriorate the patients' condition or increase the risk of postoperative morbidity. Biliary drainage can cause cholangitis/cholecystitis, pancreatitis, hemorrhage, portal vein thrombosis, bowel wall perforation, or dehydration. Two methods of preoperative biliary drainage are mostly applied: endoscopic biliary drainage, which is currently used in most regional centers before referring patients for surgical treatment, and percutaneous transhepatic biliary drainage. Both methods are associated with severe drainage-related complications, but two small retrospective series found a lower incidence in the number of preoperative complications after percutaneous drainage compared to endoscopic drainage (18-25% versus 38-60%, respectively). The present study randomizes patients with potentially resectable PHC and biliary obstruction between preoperative endoscopic or percutaneous transhepatic biliary drainage.
483. Difficult colonoscopy score identifies the difficult patients undergoing unsedated colonoscopy.
作者: Hui Jia.;Limei Wang.;Hui Luo.;Shaowei Yao.;Xiangping Wang.;Linhui Zhang.;Rui Huang.;Zhiguo Liu.;Xiaoyu Kang.;Yanglin Pan.;Xuegang Guo.
来源: BMC Gastroenterol. 2015年15卷46页
Many factors have been found to affect the difficulty of colonoscope insertion, such as age, gender, body mass index (BMI), history of abdominal surgery and operator etc. However, a scoring system may be more useful to predict the difficulty during colonoscopy.
484. Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: a double-center and double-blind randomized clinical trial.
作者: Zhihua Liu.;Chao Li.;Meijin Huang.;Chao Tong.;Xingwei Zhang.;Lei Wang.;Hui Peng.;Ping Lan.;Peng Zhang.;Nanqi Huang.;Junsheng Peng.;Xiaojian Wu.;Yanxing Luo.;Huanlong Qin.;Liang Kang.;Jianping Wang.
来源: BMC Gastroenterol. 2015年15卷34页
Colorectal liver metastases (CLM) occur frequently and postoperative intestinal infection is a common complication. Our previous study showed that probiotics could decrease the rate of infectious complications after colectomy for colorectal cancer. To determine the effects of the perioperative administration of probiotics on serum zonulin levels which is a marker of intestinal permeability and the subsequent impact on postoperative infectious complications in patients with CLM.
485. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.
作者: Paul Moayyedi.;Michael G Surette.;Peter T Kim.;Josie Libertucci.;Melanie Wolfe.;Catherine Onischi.;David Armstrong.;John K Marshall.;Zain Kassam.;Walter Reinisch.;Christine H Lee.
来源: Gastroenterology. 2015年149卷1期102-109.e6页
Ulcerative colitis (UC) is difficult to treat, and standard therapy does not always induce remission. Fecal microbiota transplantation (FMT) is an alternative approach that induced remission in small series of patients with active UC. We investigated its safety and efficacy in a placebo-controlled randomized trial.
486. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.
作者: Noortje G Rossen.;Susana Fuentes.;Mirjam J van der Spek.;Jan G Tijssen.;Jorn H A Hartman.;Ann Duflou.;Mark Löwenberg.;Gijs R van den Brink.;Elisabeth M H Mathus-Vliegen.;Willem M de Vos.;Erwin G Zoetendal.;Geert R D'Haens.;Cyriel Y Ponsioen.
来源: Gastroenterology. 2015年149卷1期110-118.e4页
Several case series have reported the effects of fecal microbiota transplantation (FMT) for ulcerative colitis (UC). We assessed the efficacy and safety of FMT for patients with UC in a double-blind randomized trial.
487. Identification of Extracolonic Pathologies by Computed Tomographic Colonography in Colorectal Cancer Symptomatic Patients.
作者: Steve Halligan.;Katherine Wooldrage.;Edward Dadswell.;Urvi Shah.;Ines Kralj-Hans.;Christian von Wagner.;Omar Faiz.;Julian Teare.;Rob Edwards.;Clive Kay.;Guiqing Yao.;Richard J Lilford.;Dion Morton.;Jane Wardle.;Wendy Atkin.; .
来源: Gastroenterology. 2015年149卷1期89-101.e5页
Symptoms suggestive of colorectal cancer may originate outside the colorectum. Computed tomographic colonography (CTC) is used to examine the colorectum and abdominopelvic organs simultaneously. We performed a prospective randomized controlled trial to quantify the frequency, nature, and consequences of extracolonic findings.
488. Cost Efficacy of Metal Stents for Palliation of Extrahepatic Bile Duct Obstruction in a Randomized Controlled Trial.
作者: Daisy Walter.;Petra G A van Boeckel.;Marcel J Groenen.;Bas L A M Weusten.;Ben J Witteman.;Gi Tan.;Menno A Brink.;Jan Nicolai.;Adriaan C Tan.;Joyce Alderliesten.;Niels G Venneman.;Wim Laleman.;Jeroen M Jansen.;Alexander Bodelier.;Frank L Wolters.;Laurens A van der Waaij.;Ronald Breumelhof.;Frank T M Peters.;Robbert C H Scheffer.;Max Leenders.;Meike M C Hirdes.;Ewout W Steyerberg.;Frank P Vleggaar.;Peter D Siersema.
来源: Gastroenterology. 2015年149卷1期130-8页
Endoscopic stents are placed for palliation of extrahepatic bile duct obstruction. Although self-expandable metal stents (SEMS) remain patent longer than plastic stents, they are more expensive. We aimed to evaluate which type of stent (plastic, uncovered SEMS [uSEMS], or partially covered SEMS [pcSEMS]) is the most effective and we assessed costs.
489. Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis.
作者: Chandan Kumar Kedarisetty.;Lovkesh Anand.;Ankit Bhardwaj.;Ajeet Singh Bhadoria.;Guresh Kumar.;Ashish Kumar Vyas.;Paul David.;Nirupama Trehanpati.;Archana Rastogi.;Chhagan Bihari.;Rakhi Maiwall.;Hitendra Kumar Garg.;Chitranshu Vashishtha.;Manoj Kumar.;Vikram Bhatia.;Shiv Kumar Sarin.
来源: Gastroenterology. 2015年148卷7期1362-70.e7页
Patients with decompensated cirrhosis have significantly reduced survival without liver transplantation. Granulocyte colony-stimulating factor (G-CSF) has been shown to increase survival in patients with acute-on-chronic liver failure, and erythropoietin promoted hepatic regeneration in animal studies. We performed a double-blind, randomized, placebo-controlled trial to determine whether co-administration of these growth factors improved outcomes for patients with advanced cirrhosis.
490. Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.
作者: Joon Hyeok Lee.;Jeong-Hoon Lee.;Young-Suk Lim.;Jong Eun Yeon.;Tae-Jin Song.;Su Jong Yu.;Geum-Youn Gwak.;Kang Mo Kim.;Yoon Jun Kim.;Jae Won Lee.;Jung-Hwan Yoon.
来源: Gastroenterology. 2015年148卷7期1383-91.e6页
No adjuvant therapy has been shown to extend the survival of patients with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated whether injections of activated cytokine-induced killer (CIK) cells (CD3+/CD56+ and CD3+/CD56- T cells and CD3-/CD56+ natural killer cells) prolongs recurrence-free survival of patients after curative therapy for HCC.
491. Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease.
作者: Niels Vande Casteele.;Marc Ferrante.;Gert Van Assche.;Vera Ballet.;Griet Compernolle.;Kristel Van Steen.;Steven Simoens.;Paul Rutgeerts.;Ann Gils.;Séverine Vermeire.
来源: Gastroenterology. 2015年148卷7期1320-9.e3页
Infliximab, a tumor necrosis factor antagonist, is effective for treating patients with Crohn's disease (CD) and ulcerative colitis (UC). We aimed to determine whether dosing based on therapeutic drug monitoring increases rate of remission and whether continued concentration-based dosing is superior to clinically based dosing of infliximab for maintaining remission in patients with CD and UC.
492. Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial.
作者: Daniel A Leffler.;Ciaran P Kelly.;Peter H R Green.;Richard N Fedorak.;Anthony DiMarino.;Wendy Perrow.;Henrik Rasmussen.;Chao Wang.;Premysl Bercik.;Natalie M Bachir.;Joseph A Murray.
来源: Gastroenterology. 2015年148卷7期1311-9.e6页
Celiac disease (CeD) is a prevalent autoimmune condition. Recurrent signs and symptoms are common despite treatment with a gluten-free diet (GFD), yet no approved or proven nondietary treatment is available.
493. Cap assisted colonoscopy for the detection of serrated polyps: a post-hoc analysis.
作者: Fadi Rzouq.;Neil Gupta.;Sachin Wani.;Prateek Sharma.;Ajay Bansal.;Amit Rastogi.
来源: BMC Gastroenterol. 2015年15卷11页
Colonoscopy offers limited protection against right-sided colon cancer, a significant proportion of which arise from the serrated pathway of carcinogenesis. The aim of this study was to compare cap-assisted colonoscopy and standard high-definition white light colonoscopy regarding serrated polyps' detection.
494. Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes.
作者: Julián Panés.;Chinyu Su.;Andrew G Bushmakin.;Joseph C Cappelleri.;Carla Mamolo.;Paul Healey.
来源: BMC Gastroenterol. 2015年15卷14页
Tofacitinib, a novel, oral Janus kinase inhibitor, demonstrated a dose-dependent efficacy for induction of clinical response and remission in patients with active ulcerative colitis (UC). The objective of the current study was to determine the effect of tofacitinib on patient-reported outcomes (PROs).
495. Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis.
作者: William J Sandborn.;Brian Bosworth.;Salam Zakko.;Glenn L Gordon.;David R Clemmons.;Pamela L Golden.;Robert L Rolleri.;Jing Yu.;Andrew C Barrett.;Enoch Bortey.;Craig Paterson.;William P Forbes.
来源: Gastroenterology. 2015年148卷4期740-750.e2页
Budesonide is a high-potency, second-generation corticosteroid designed to minimize systemic adverse consequences of conventional corticosteroids. We performed 2 randomized, phase 3 trials to evaluate the ability of budesonide rectal foam, formulated to optimize retention and provide uniform delivery of budesonide to the rectum and distal colon, to induce remission in patients with ulcerative proctitis or ulcerative proctosigmoiditis.
496. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
作者: Emily K Wright.;Michael A Kamm.;Peter De Cruz.;Amy L Hamilton.;Kathryn J Ritchie.;Efrosinia O Krejany.;Steven Leach.;Alexandra Gorelik.;Danny Liew.;Lani Prideaux.;Ian C Lawrance.;Jane M Andrews.;Peter A Bampton.;Simon L Jakobovits.;Timothy H Florin.;Peter R Gibson.;Henry Debinski.;Finlay A Macrae.;Douglas Samuel.;Ian Kronborg.;Graeme Radford-Smith.;Warwick Selby.;Michael J Johnston.;Rodney Woods.;P Ross Elliott.;Sally J Bell.;Steven J Brown.;William R Connell.;Andrew S Day.;Paul V Desmond.;Richard B Gearry.
来源: Gastroenterology. 2015年148卷5期938-947.e1页
Crohn's disease (CD) usually recurs after intestinal resection; postoperative endoscopic monitoring and tailored treatment can reduce the chance of recurrence. We investigated whether monitoring levels of fecal calprotectin (FC) can substitute for endoscopic analysis of the mucosa.
497. Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population.
作者: Douglas K Rex.;Samuel N Adler.;James Aisenberg.;Wilmot C Burch.;Cristina Carretero.;Yehuda Chowers.;Steven A Fein.;Steven E Fern.;Ignacio Fernandez-Urien Sainz.;Alexander Fich.;Eyal Gal.;John C Horlander.;Kim L Isaacs.;Revital Kariv.;Adi Lahat.;Wai-Keung Leung.;Pramod R Malik.;Doug Morgan.;Neofytos Papageorgiou.;David P Romeo.;Smita S Shah.;Matti Waterman.
来源: Gastroenterology. 2015年148卷5期948-957.e2页
Capsule colonoscopy is a minimally invasive imaging method. We measured the accuracy of this technology in detecting polyps 6 mm or larger in an average-risk screening population.
498. A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection.
作者: Hiroaki Takahashi.;Yoshiaki Arimura.;Satoshi Okahara.;Junichi Kodaira.;Kaku Hokari.;Hiroyuki Tsukagoshi.;Yasuhisa Shinomura.;Masao Hosokawa.
来源: BMC Gastroenterol. 2015年15卷1页
Esophageal stenosis following endoscopic submucosal dissection (ESD) is a serious adverse event that makes subsequent management more difficult.
499. The combination of simeprevir and sofosbuvir is more effective than that of peginterferon, ribavirin, and sofosbuvir for patients with hepatitis C-related Child's class A cirrhosis.
作者: Brian L Pearlman.;Carole Ehleben.;Michael Perrys.
来源: Gastroenterology. 2015年148卷4期762-70.e2; quiz e11-2页
The efficacy and safety of interferon-free regimens for the treatment of chronic hepatitis C virus (HCV) infections require further evaluation and comparison with those of interferon-containing regimens. We compared a regimen of peginterferon, ribavirin, and sofosbuvir with a regimen of simeprevir and sofosbuvir in patients with HCV infection and unfavorable treatment features.
500. A point-of-care test for facing the burden of undiagnosed celiac disease in the Mediterranean area: a pragmatic design study.
作者: Stefano Costa.;Luca Astarita.;Mongi Ben-Hariz.;Giovanni Currò.;Jernej Dolinsek.;Aydan Kansu.;Giuseppe Magazzu'.;Stefania Marvaso.;Dusanka Micetic-Turku.;Salvatore Pellegrino.;Giuseppe Primavera.;Pasqualino Rossi.;Andrea Smarrazzo.;Francesca Tucci.;Carmela Arcidiaco.;Luigi Greco.
来源: BMC Gastroenterol. 2014年14卷219页
We aimed at assessing the factors that can influence results of the dissemination of an already validated, new generation commercial Point-of-Care Test (POCT) for detecting celiac disease (CD), in the Mediterranean area, when used in settings where it was designed to be administered, especially in countries with poor resources.
|